india glp 1 GLP-1 Receptor Agonist Market Size & Outlook, 2033 India pharma companies develop versions
Description
Also, it will have an impact on the broader ecosystem of healthcare services, potentially changing your patients population characteristics and their journey
The incretin, glucagon-like peptide-1 (GLP-1) is an endogenous peptide hormone secreted from intestinal endocrine cells in response to food intake 1
Some studies propose potentially cardioprotective and renoprotective actions, while others highlight an enhanced vulnerability of some DPP-4 inhibitors to cause heart failure
The other is an oral dose
Together, these actions help stabilize energy levels and limit overeating
